(E/Z) -4-Hydroxytamoxifen
Afimoxifene, the (E/Z) -4-hydroxylated metabolite of tamoxifen, is a selective estrogen receptor modulator (SERM) used in research. It is applied in studies of estrogen-dependent conditions such as breast cancer, gynecomastia, and mastalgia, utilizing both in vitro and in vivo experimental models.
Product Specifications
CAS Number
68392-35-8
Product Name Alternative
Inhibit, Estrogen Receptor, EstrogenReceptor, Estrogen Receptor/ERR, ERR, ER, Endogenous Metabolite, Inhibitor, (E/Z) 4 Hydroxytamoxifen, (E/Z) 4Hydroxytamoxifen, (E/Z) -4-Hydroxytamoxifen, 4-Hydroxytamoxifen, Afimoxifene, progestogen Receptor, progestogenReceptor
Field of Research
Metabolism Research
Purity
≥98% (May vary between batches)
Solubility
DMSO:60 mg/mL (154.83 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.16 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)
Smiles
CC\C (=C (/c1ccc (O) cc1) c1ccc (OCCN (C) C) cc1) c1ccccc1
Molecular Formula
C26H29NO2
Molecular Weight
387.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15091740 1 Vial
Lentiviral human KAAG1 shRNA (UAS) - Lentiviral human KAAG1 shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details 